SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001193125-23-151506
Filing Date
2023-05-23
Accepted
2023-05-23 12:38:00
Documents
2
Group Members
JAMES DONOVAN

Document Format Files

Seq Description Document Type Size
1 SC 13G d499682dsc13g.htm SC 13G 52809
2 EX-99.1 d499682dex991.htm EX-99.1 3429
  Complete submission text file 0001193125-23-151506.txt   57975
Mailing Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609
Business Address 4830 W. KENNEDY BLVD. SUITE 600 TAMPA FL 33609 (813) 766-2462
Inhibitor Therapeutics, Inc. (Subject) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-51823 | Film No.: 23947637
SIC: 2834 Pharmaceutical Preparations

Mailing Address 12412 POWERSCOURT DRIVE SUITE 35 SAINT LOUIS MO 63131
Business Address 12412 POWERSCOURT DRIVE SUITE 35 SAINT LOUIS MO 63131 3143942104
TPB 2012 LLC (Filed by) CIK: 0001978542 (see all company filings)

IRS No.: 376521488 | State of Incorp.: NV | Fiscal Year End: 1231
Type: SC 13G